Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Dianthus Therapeutics, Inc. /DE/ | CHIEF MEDICAL OFFICER | Common Stock | 4K | $48K | $12.00 | Sep 22, 2023 | Direct |
Dianthus Therapeutics, Inc. /DE/ | CHIEF MEDICAL OFFICER | Stock Option (Right to Buy) | 100K | May 23, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DNTH | Dianthus Therapeutics, Inc. /DE/ | May 23, 2024 | 1 | $0 | 4 | May 28, 2024 | CHIEF MEDICAL OFFICER |
DNTH | Dianthus Therapeutics, Inc. /DE/ | Jan 24, 2024 | 1 | $0 | 4 | Jan 26, 2024 | CHIEF MEDICAL OFFICER |
MGTA | Dianthus Therapeutics, Inc. /DE/ | Sep 21, 2023 | 2 | $52.8K | 4 | Sep 25, 2023 | Chief Medical Officer |
MGTA | Dianthus Therapeutics, Inc. /DE/ | Sep 11, 2023 | 0 | $0 | 3 | Sep 13, 2023 | Chief Medical Officer |